Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

MANKIND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹1,705 Cr₹8.68 Cr₹48 Cr₹16 Cr₹-36 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of MANKIND PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of MANKIND PHARMA is ₹1,705 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹1,705 Cr
Mar2024₹8.68 Cr
Mar2023₹48 Cr
Mar2022₹16 Cr
Mar2021₹-36 Cr

How is Deferred Tax Assets / Liabilities of MANKIND PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹1,705 Cr
19,538.48
Mar2024 ₹8.68 Cr
-81.74
Mar2023 ₹48 Cr
191.02
Mar2022 ₹16 Cr
Positive
Mar2021 ₹-36 Cr -

Compare Deferred Tax Assets / Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹86,787.1 Cr -4.8% 1% -4.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,782.0 Cr -2.5% 4.7% 7.1% Stock Analytics
DIVIS LABORATORIES ₹163,125.0 Cr -2.1% -0.2% 7.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,252.0 Cr -3.4% 0.7% 39.1% Stock Analytics
DR REDDYS LABORATORIES ₹108,025.0 Cr -1.9% 2% 16.1% Stock Analytics
CIPLA ₹102,443.0 Cr -4.3% -6.5% -11.9% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-4.8%

1%

-4.7%

SENSEX

-0.2%

-7.2%

3.5%


You may also like the below Video Courses